loading

Breakfast

09:00 Session 11 – Necroptosis, death receptors and inflammation
Chairs: Mads Gyrd-Hansen; Anja Krippner-Heidenreich

Annette Jacobsen, Walter + Eliza Hall Institute of Medical Research
Compound X is a novel inhibitor of necroptosis in human cell lines.

Emma Petrie, Walter + Eliza Hall Institute of Medical Research
Formation of active human MLKL oligomers is tightly controlled by RIPK3.

Uris Ros, University of Tubingen
Structural insights into the auto-regulation of the necroptosis executor MLKL

Gabriela Brumatti, Walter + Eliza Hall Institute of Medical Research
RIPping leukaemias apart: Exploiting necroptosis to treat Acute Myeloid Leukaemia

Maximilien Bencze, UCL Great Ormond Street Institute of Child Health
Necroptosis participates in skeletal muscle degeneration in Duchenne Muscular Dystrophy

Graeme Sullivan, Trinity College
ER Stress-induced TRAIL receptor upregulation promotes inflammation

 

10:30 Coffee break

11:00 Session 12 – Gamechanging Science 2
Chairs: Gabriella Brumatti; Thomas Kaufmann

Mary Speir, Harvard Medical School
Negative regulation of apoptotic and necroptotic cell death by SHP1

Lisa Schlicher, Ludwig Institute for Cancer Research
Small-molecule inhibitors reveal an indispensable scaffolding role of RIPK2 in NOD2 signalling

Ben Croker, Harvard Medical School
PAD4 negatively regulates neutrophil necroptosis

Paula Kroon, The Netherlands Cancer Institute
Hype, hope, or something in between? Achieving abscopal effects by radio-immunotherapy approaches

Nicole Rufo KU Leuven
Systems Biology of Immunogenic Cell Death (ICD) in Melanoma

Irmina Garcia-Carpio, Medical University of Innsbruck
Dissecting the molecular basis of sterile inflammation upon centrosome aberrations

 

12:30 Lunch

14:30  Session 13 – Gut
Chairs: Geert van Loo; Monica Yabal

Adam Wahida, Technical University of Munich
Molecular Characterization of the TNF-RIPK3-axis in Paneth cell Dysfunction and Dysbiosis as drivers of Inflammatory Bowel Disease in XIAP-Deficiency

Marc Healy, University Hospital Zurich
MCL-1 suppresses intestinal carcinogenesis by ensuring mucosal and stem cell homeostasis independent of microbiota-driven inflammation

Christa Kietz, Åbo Akademi University
drICE restrains DIAP2-mediated inflammatory signalling and intestinal inflammation

Eugenia Delgado, Ecole Polytechnique Federale de Lausanne
LRH-1-dependent regulation of intestinal epithelial cell death

Eric Chapman, University of Toronto
A conserved CCM complex promotes apoptosis non-autonomously by regulating zinc homeostasis in C. elegans

 

16:00 Football tournament

20.30 Gala Dinner